Erik van Zandbergen
Erik van Zandbergen
Chief Operating Officer
Erik joined Julius Clinical in January 2019. His primary drive is to get new therapies to patients through impeccable service delivery to clients.
Related
Julius Clinical Expands CNS and Cardiometabolic Capabilities with Post-Merger Growth and New Operations in Spain and Germany
Zeist, The Netherlands – [Date] – Julius Clinical, a leading clinical Contract Research Organization (CRO) with deep therapeutic expertise in CNS and Cardiometabolic indications, today announced continued growth in bookings in these key therap...
Whitepaper: Risk-Based Quality Management (RBQM)
📄 About This Document Learn how Risk-Based Quality Management (RBQM) can enhance the quality, efficiency, and oversight of clinical trials. This one-pager outlines the key principles of RBQM, its core components, and insights from a case study...
Is MASH the most silent disease everyone is talking about?
Interview 3rd June 2025Julius Clinical sat down with Professor Helena Cortez-Pinto (MD, PhD), a gastroenterology and hepatology specialist with a particular interest in steatotic liver disease, nutrition, and public health, to talk about metab...
